Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
Clinical trial NCT01014351 · COMPLETED
Trial details
- NCT number
- NCT01014351
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.